SCHEMBL4316458

SCHEMBL4316458

O=C(O)[C@H](Br)Cc1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.61
ALPI P09923 1/20 0.57
PKM P14618 1/20 0.57
PTGS1 P23219 1/20 0.57
XIAP P98170 1/20 0.57
SLC7A5 Q01650 1/20 0.57
CPA1 P15085 6/20 0.53
CPA3 P15088 3/20 0.53
FOLH1 Q04609 1/20 0.53
CPB1 P15086 1/20 0.53
CPB2 Q96IY4 1/20 0.53
SRR Q9GZT4 2/20 0.52
SLC1A3 P43003 2/20 0.52
SLC1A2 P43004 2/20 0.52
SLC1A1 P43005 2/20 0.52
NPSR1 Q6W5P4 1/20 0.50
HSD17B10 Q99714 1/20 0.50
MDM2 Q00987 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL490844 1.00 CYP1A2 (0.61) CYP1A2ALPIPKMPTGS1XIAP
SCHEMBL4826192 1.00 CYP1A2 (0.61) CYP1A2ALPIPKMPTGS1XIAP
Bromide SCHEMBL1596942 0.98 CYP1A2 (0.59) CYP1A2ALPIPKMPTGS1XIAP
Ethylenediamine SCHEMBL5766632 0.92 ALPI (0.55) CYP1A2ALPIPKMPTGS1XIAP
Toluene SCHEMBL6466953 0.90 CYP1A2 (0.52) CYP1A2ALPIPKMPTGS1XIAP
Toluene SCHEMBL6466957 0.90 CYP1A2 (0.52) CYP1A2ALPIPKMPTGS1XIAP
Acetonitrile SCHEMBL27829383 0.89 CYP1A2 (0.50) CYP1A2ALPIPKMPTGS1XIAP
Nitrous Acid SCHEMBL9333501 0.89 CYP1A2 (0.50) CYP1A2ALPIPKMPTGS1XIAP
SCHEMBL6382096 0.88 SRR (0.57) PTGS1CPA1SRR
SCHEMBL5766696 0.87 CYP1A2 (0.48) CYP1A2ALPIPKMPTGS1XIAP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 228 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7388098-B2 Dynamic resolution of isomers and resolved isomers BRISTOL-MYERS SQUIBB COMPANY (US) 2008-06-17 US claimed
EP-1487836-B1 ETHANE-1,2-DIAMINO-BIS (2R)-2-BROMO-3-PHENYLPROPANOATE|, METHOD FOR PRODUCTION AND USE THEREOF SANOFI AVENTIS DEUTSCHLAND (DE) 2006-09-06 EP claimed
US-7009047-B2 Ethane-1,2-diaminium bis[(2R)-2-bromo-3-phenylpropanoate], processes for its preparation and its use SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2006-03-07 US claimed
CN-1639109-A Kinetic resolution of isomers and resolved isomers BRISTOL MYERS SQUIBB CO (US) 2005-07-13 CN claimed
EP-1056707-B1 PROCESS FOR PREPARING (R)-2-BROMO-3-PHENYL-PROPIONIC ACID ZAMBON SPA (IT) 2004-12-22 EP claimed
EP-1487836-A1 ETHANE-1,2-DIAMINO-BIS (2R)-2-BROMO-3-PHENYLPROPANOATE], METHOD FOR PRODUCTION AND USE THEREOF Aventis Pharma Deutschland GmbH (DE) 2004-12-22 EP claimed
EP-1138671-B1 Production method of aromatic acylthiocarboxylic acid derivative AJINOMOTO KK (JP) 2004-09-01 EP claimed
US-20040010039-A1 Ethane-1,2-diaminium bis[(2R)-2-bromo-3-phenylpropanoate], processes for its preparation and its use DEUTSCHE BANK AG NEW YORK BRANCH 2004-01-15 US claimed
WO-2003078434-A1 ETHANE-1,2-DIAMINO-BIS[(2R)-2-BROMO-3-PHENYLPROPANOATE], METHOD FOR PRODUCTION AND USE THEREOF AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2003-09-25 WO claimed
EP-1324975-A2 DYNAMIC RESOLUTION OF ISOMERS AND RESOLVED ISOMERS Bristol-Myers Squibb Company (US) 2003-07-09 EP claimed
US-20020010358-A1 Production method of aromatic carboxylic acid derivative AJINOMOTO CO., INC. (JP) 2002-01-24 US claimed
EP-1138671-A1 Production method of aromatic acylthiocarboxylic acid derivative Ajinomoto Co., Inc. (JP) 2001-10-04 EP claimed
WO-2001058837-A2 PROCESS FOR THE PREPARATION OF (R)-2-BROMO-3-PHENYL-PROPIONIC ACID DSM N.V. (NL) 2001-08-16 WO claimed
WO-2001058865-A1 METHOD FOR THE PREPARATION OF (S)-2-ACETYLTHIO-3-PHENYLPROPIONIC ACID DSM N.V. (NL) 2001-08-16 WO claimed
EP-1056707-A1 PROCESS FOR PREPARING (R)-2-BROMO-3-PHENYL-PROPIONIC ACID ZAMBON GROUP S.p.A. (IT) 2000-12-06 EP claimed
EP-1056715-A1 PROCESS FOR PREPARING 2-ACETYLTHIO-3-PHENYL-PROPIONIC ACID AND THE SALTS THEREOF ZAMBON GROUP S.p.A. (IT) 2000-12-06 EP claimed
US-6103931-A Process for preparing (R)-2-bromo-3-phenyl-propionic acid ZAMBON GROUP S.P.A. (IT) 2000-08-15 US claimed
US-6080881-A Process for preparing 2-acetythio-3-phenyl-propionic acid and the salts thereof ZAMBON GROUP S.P.A. (IT) 2000-06-27 US claimed
WO-1999042438-A1 PROCESS FOR PREPARING 2-ACETYLTHIO-3-PHENYL-PROPIONIC ACID AND THE SALTS THEREOF ZAMBON GROUP S.P.A. (IT) 1999-08-26 WO claimed
WO-1999042431-A1 PROCESS FOR PREPARING (R)-2-BROMO-3-PHENYL-PROPIONIC ACID ZAMBON GROUP S.P.A. (IT) 1999-08-26 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020010358-A1 Production method of aromatic carboxylic acid derivative AADAC, DDC, AADAT CYP1A2 299/4885ALPI 2302/4885PKM 3743/4885
US-20040010039-A1 Ethane-1,2-diaminium bis[(2R)-2-bromo-3-phenylpropanoate], processes for its preparation and its use ACE, ECE1, ECE2 CYP1A2 427/4885ALPI 2674/4885PKM 1266/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.